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Aims and Objectives 
 
 
 
1. To create an animal model for carcinogen induced gastric 
cancer in rats 
 
 
 
2. To Study the effect of aspirin and vitamin C in modifying the 
progression of gastric cancer induced by carcinogen in the 
animal model 
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Introduction 
 
 
 
 
 
Gastric cancer is one of the leading causes of death amongst cancer 
patients. It is surpassed only by lung cancer as the most common of the 
malignancies. Delay in the diagnosis of gastric cancer is one the main 
causes for its lethal nature. The pathogenesis of gastric cancer is a 
complex process involving different stages of development in malignancy 
ranging from chronic active gastritis to dysplasia and metaplasia and 
eventually, malignancy. A number of causative factors have been 
implicated in the transformation of normal gastric mucosa into malignant 
cells. Environmental factors include infection by H. pylori, presence of 
nitrites in the food which act as carcinogens (nitrosamines) and lack of 
fresh fruit and vegetables. Host factors include chronic gastritis and 
partial gastrectomy status which favors reflux of bile and alkaline 
intestinal secretions.  Patients with blood group A have been found to be 
more susceptible to gastric cancer. A positive family history, hereditary 
non-polyposis colon cancer syndrome and familial gastric carcinoma 
syndrome (E-cadherin mutation) suggest that genetic factors seem to have 
a role in the predisposition to gastric cancer.  Among the environmental 
factors, an important one seems to be exposure to carcinogen, perhaps in 
the diet. There is a world wide geographic distribution of gastric cancer 
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with higher incidence in countries like Japan and some parts of South 
America and lower incidences in Western Europe and United States. 
Studies done on migrant population, those who have moved in to areas of 
low incidence from areas of high incidence, have shown that 
environmental, genetic and cultural factors seem to influence 
predisposition to gastric cancer. (1) 
 
This study aims at producing a gastric cancer model in rats using a 
carcinogen to induce malignancy. As carcinogens, mainly nitrosamines, 
in the diet have been implicated in causing gastric cancer; this study aims 
at using a carcinogen, a nitrosamine, to induce gastric cancer in rats. With 
such a model in mind, the study also aims to look at the influence of 
Aspirin and Vitamin C in modifying the progression of gastric cancer 
induced by the carcinogen. 
 
The results of this study, if found to be significant, could be used for 
further study in a human model. As gastric cancer propagates through 
various stages of development, could Aspirin be used to alter the 
progression of disease if picked up early by gastroscopy is the question 
under study. The implications of this study being that if a patient has been 
diagnosed to have any early features of malignancy which may include 
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chronic atrophic gastritis or dysplasia , does long term intake of aspirin 
prevent progression of disease?  
 
This study aims to determine if this would be possible on an animal 
model. 
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Review of Literature 
 
 
 
 
Carcinogen: 
 
 
 
The most important of the environmental factors responsible for causing 
gastric cancer seems to be exposure to carcinogens, more specifically 
nitrosamines. Numerous nitrosamine compounds have been studied and 
animal experiments have been conducted to study the carcinogenic 
properties by Lijinsky and many others (2). Approximately 300 different 
Nitrosamines have carcinogenic potential. Different animal species show 
carcinogenic response to these chemicals. Exposure to sufficient 
quantities of these compounds can also induce cancer in humans. 
Exposure to these compounds can occur through diet, occupational 
exposure, use of tobacco products, cosmetics, pharmaceutical products 
and agricultural chemicals (5).   
 
 
 
Mechanism of action: 
 
 
 
Extensive studies of these compounds have shown that they, by 
themselves are not carcinogenic. However, after enzymatic oxidative 
metabolism, they are converted into a precursor of the final carcinogen. 
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There is considerable evidence to show that damage to cellular DNA and 
proteins by electrophiles generated from these metabolites may be 
responsible for their characteristic biological effects. Certain DNA base 
lesions, particularly Guanine O6 alkylation are apparently more critical in 
giving rise to cell transformation than others, e.g. N7 alkylation. It has 
been demonstrated that, of the possible sites of enzymatic oxidation, 
hydroxylation at the positions α to the N-nitroso group ultimately 
produces the carcinogen. The resulting α-hydroxymethylnitrosamines 
have been suggested to lose formaldehyde readily to generate the primary 
alkylnitrosamine which tautomerizes to the alkanediazohydroxide. The 
latter being a powerful electrophile alkylates sensitive cellular 
nucleophiles, including DNA base sites. The α-
acetoxymethylalkylnitrosamines are especially pertinent since they have 
been shown to be potent carcinogens. (6). 
 
In this study, the carcinogen chosen was Nitrosopiperidine, a member of 
the nitrosamine group.  
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N-Nitrosopiperidine 
 
 
 
 
 
 
 
 
Properties:  
 
N-Nitrosopiperidine is a yellow oil. It is soluble in water, organic 
solvents, lipids, and hydrochloric acid. It decomposes when exposed 
to light, and is especially sensitive to ultraviolet light. When heated to 
decomposition, it emits toxic fumes of nitrogen oxides. It is oxidized 
by strong oxidants to the corresponding nitramine and it can be 
reduced to the corresponding hydrazine and/or amine. It is relatively 
resistant to hydrolysis, but can be reduced by hydrogen bromide in 
acetic acid 
 
Carcinogenicity: 
 
N-Nitrosopiperidine is reasonably anticipated to be a human carcinogen 
based on sufficient evidence of carcinogenicity in experimental animals. 
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When administered in the diet, N-nitrosopiperidine 
induced squamous cell carcinomas of the forestomach, papillomas of the 
esophagus, hepatocellular adenomas and carcinomas, and liver 
hemangioendotheliomas in male mice. When administered in drinking 
water, N-nitrosopiperidine induced lung adenomas in mice of both sexes 
and esophageal carcinomas and hepatocellular carcinomas in rats. When 
administered orally, N-nitrosopiperidine induced hepatocellular 
carcinomas in monkeys. When administered by subcutaneous injection, 
the compound induced squamous cell carcinomas and other tumours of 
the nasal cavity, esophageal squamous cell carcinomas and papillomas in 
rats.  Tumours of the nasal cavity, trachea, lung, tongue, palate, 
esophagus, forestomach, and liver were seen in hamsters. When 
administered by intraperitoneal injection, N-nitrosopiperidine increased 
the incidence of adenomas of the lung in mice. When administered by 
intravenous injection, the compound induced carcinomas of the 
esophagus and pharynx in rats. When administered to pregnant hamsters, 
a low incidence of tumours of the upper respiratory tract was observed for 
the offspring and a high incidence of respiratory tract tumours was 
observed for the mothers (IARC 1978, 1987). 
So far there are no adequate human studies on the relationship between 
exposure to N-nitrosopiperidine and cancer. 
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Use : 
 
N-Nitrosopiperidine is used as a research chemical; no other uses have 
been identified. 
 
 
 
 
N-METHYL-N'-NITRO-N-NITROSOGUANIDINE 
(MNNG) 
 
 
 
 
Amongst the carcinogens used in experiments to induce stomach cancer, 
MNNG is the most important one, used exclusively to induce gastric 
cancer.  MNNG induced DNA strand breaks in various organs of rats 
treated in vivo. It did not cause dominant lethal mutations in mice, but it 
gave positive results for mutation in the mouse spot test; it induced 
chromosomal aberrations and micronuclei in bone-marrow cells of mice 
and sister chromatid exchanges in bone-marrow cells of mice and 
Chinese hamsters treated in vivo. It induced chromosomal aberrations, 
sister chromatid exchanges, DNA strand breaks and unscheduled DNA 
synthesis in human and rodent cells in vitro and induced mutation in 
cultured rodent cells. It gave positive results in several assays for cell 
transformation. MNNG induced somatic and sex-linked recessive lethal 
mutations in Drosophila. It caused chromosomal aberrations, sister 
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chromatid exchanges and mutation in plants and recombination and 
mutation in fungi. It was mutagenic to and caused DNA damage in 
bacteria, and gave positive results in host-mediated assays using bacteria 
or yeast as indicators and mice as hosts (7). 
 
MNNG has been tested for carcinogenicity in mice, rats, hamsters, rabbits 
and dogs, producing tumours at many sites. It has a predominantly local 
carcinogenic effect and is carcinogenic in single-dose experiments. 
Following its oral administration, papillomas and squamous-cell 
carcinomas of the oesophagus and forestomach, adenocarcinomas of the 
stomach, small intestine and large bowel, and sarcomas of the 
gastrointestinal tract were reported. These findings have been extended in 
more recent studies after oral administration to rats, hamsters and dogs. 
After subcutaneous injection in mice, it produced lung and liver tumours 
and haemangioendotheliomas; after intrarectal, intrauterine and 
intravaginal application in rats and guinea-pigs, it produced local 
tumours. (7). 
 
 P.J. Hu and his colleagues conducted an experiment on 86 male wistar 
rats using MNNG to induce stomach cancer and study the 
chemopreventive effect of Celecoxib. This compound, when administered 
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orally with drinking water induced stomach cancer in 75% of the rats 
given MNNG only (8). 
 
This study was initially designed using MNNG as the carcinogen. 
However, due to the nonavailability of this drug, another carcinogen, 
Nitrosopiperidine was chosen.  
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The Rat:  
 
 
 
Rats are the most commonly used animal for conducting experiments, 
next only to the mouse. Animal studies on rats include those involving 
Nutrition, transplantation, immunology, genetics, pharmacology and 
cancer research, to name a few.  
  
 
Rat strains descendent from Wistar:  
 
 
 
 
Genealogy of out bred rat strains: 
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General characteristics of Rats: 
 
 
 
Rats have a well developed diurnal rhythm. They are active during the 
dark and rest during the light hours. Feeding occurs in the night and 
digestion during the early daylight hours. During this period, caged rats 
can easily be handled.  The mean life span of male out bred rats is around 
1000 days and females 1300 days but inbred generally have shorter life 
spans.  
 
Wistar rats are an out bred strain of albino rats. They belong to the 
species Rattus norvegicus. This strain was originally developed in the 
Wistar Institute. Its purpose was mainly for biological and medical 
research, and is notably the first rat strain to be developed to serve as a 
model organism. The large size of the rat is apt for conducting procedures 
which would be difficult to perform in mice.  Most laboratory rat strains 
are descended from a colony of rats established at the Wistar Institute in 
1906 by Henry Donaldson, Milton. J. Greenman and Helen Dean King. 
The Wistar rat is currently one of the most popular rat strains used to 
laboratory research. It is characterized by its wide head, long ears, and 
having a tail length that is always less than its body length. The Sprague 
Dawley rat and Long-Evans rat strains were developed from Wistar rats. 
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Resistance to tumour induction:  
 
 
 
 
Hiroko and colleagues conducted experiments in rats to study their 
genetic susceptibility to gastric carcinoma after treatment with 
carcinogen, MNNG. They found that resistance to induction of gastric 
adenocarcinoma by MNNG was a dominant characteristic (9).  There are 
a few resistant strains of rats that resist the induction of tumours. Can this 
trait be isolated and then studied in humans? The answer to this question 
can only be obtained by continual research at molecular level to study the 
genes responsible for these traits. 
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Basic biological data 
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Environmental requirements for the comfort and well 
being of laboratory rats and mice (From Clough, 
1992): 
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Non–Steroidal Anti-inflammatory Drugs – 
Their Role in Chemo-prevention 
 
 
 
Patients with Rheumatoid arthritis were found to have lower incidences 
of gastrointestinal malignancies (3, 4). Many studies have shown this to 
be true. This was thought to be due to the ingestion of Non Steroidal 
Anti-inflammatory Drugs. This theory was proved by both observational 
and controlled epidemiological studies in patients with colo-rectal cancer.   
 
In a population based case-control study K. Akre and colleagues, in 5 
Swedish counties, interviewed 567 incident cases of gastric cancer and 
1165 controls were interviewed.  The cases were uniformly classified to 
subsite (cardia or non-cardia) and histological type and information 
collected on other known risk factors for gastric cancer. Users of Aspirin 
had a moderately reduced risk of gastric cancer compared to never users 
(odd ratio adjusted for age, gender and socio-economic status was 0.7 (95 
% CI = 0.6 – 1.0)). Gastric cancer risk fell with increasing frequency of 
aspirin use (p = 0.02). The risk reduction was apparent for both cardia 
and non-cardia tumours but not so certain for the diffuse type.  No other 
association was observed between gastric cancer and non-aspirin NSAIDs 
or other studied pain relievers. These findings led to the hypothesis that 
use of aspirin reduces the risk of gastric cancer (10).  
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Results from an American population based case-control study showed 
odds ratios of 0.55 for gastric adenocarcinomas and 0.88 (not statistically 
significant) for gastric cardia adenocarcinoma among regular users of 
aspirin, compared to never users (Farrow et al, 1998). With the same 
exposure categories, a hospital–based case-control study from Moscow 
reported an odds ratio of 0.49 and 1.14 (not statistically significant) for 
non-cardia and cardia cancer, respectively (Zaridze et al, 1999).  
 
The relationship of Aspirin use and esophageal cancer was examined 
using data from the National Health and Nutrition Examination Survey 
(NHANES 1) and the National Epidemiologic Follow-up Studies 
(NEFS). Persons were classified as nonusers, occasional users or regular 
users of aspirin based on their response to two questions at the base-line 
examination: whether they had taken aspirin in the last 30 days and 
whether they had used pain medications regularly during the prior 6 
months.  Occasional use was associated with a 90 % decreased risk (95% 
CI, 0.01-0.76) of developing esophageal cancer; none of the regular users 
developed the disease. Adjusting for cigarette smoking (ever .vs. never) 
and alcohol intake (at least monthly .vs. not) did not explain the findings 
(11). 
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C57BL/6 mice were treated with a carcinogen N-methyl Nitrosourea 
(MNU) and/or H. pylori. Nimesulide (NSAID) was mixed with feed 
pellets and administered for the duration of the experiment. Gastric 
tumours developed in 68.8 % of mice that were given both MNU and H. 
pylori, where as less than 10% developed gastric cancer when given 
either MNU or H. pylori alone. In mice treated with both MNU and H. 
pylori, nimesulide administration substantially decreased H. pylori 
associated gastric tumorigenesis, where as substantial inductions of 
apoptosis were observed. (12). 
 
This property of Aspirin and non-aspirin NSAIDs was thought to be due 
to its inhibitory action on Cyclo-oxygenase II enzyme. 
Kirsi Saukkonen and his colleagues studied the expression of COX-2 
expression in human gastric dysplasias and adenocarcinomas. 
Performance of several COX-2 antibodies was evaluated, after which 
COX-2 protein expression was studied in 67 gastric cancer specimens and 
in 8 definite dysplasias by using immunohistochemistry. COX-2 
positivity was detected in 58% of the intestinal type (well differentiated) 
tumours and 6 % of diffuse –type (poorly differentiated) tumours. There 
was a higher expression of COX-2 mRNA, protein and enzymatic activity 
in well-differentiated gastric cancer cell lines when compared with poorly 
differentiated cell lines. COX-2 immuno-reactivity was localised to the 
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carcinoma cells, the stroma of the tumours was negative. Strong COX-2 
positivity was consistently detected in stromal cells at sites of erosions 
and ulcerations. Moreover 44 % definite dysplasias of the stomach that 
showed no evidence of invasion were positive for COX-2(13). 
 
Having proved that there is over expression of COX-2 by the cancer cells, 
it was thought that the mechanism of action of aspirin and non-aspirin 
NSAIDs was by inhibition of this enzyme. After the discovery of over 
expression of COX-2, selective COX-2 inhibitors were being used in 
experiments to study their chemo-preventive role.  
 
P. J. Hu et al divided 86 male Wistar rats into 6 different treatment 
groups. 
Group A – Water alone (n=5) 
Group B – N-methyl-N’-nitro-N-nitrosoguanidine (MNNG 100 
microgram/ml) (n=16) 
Group C – Indomethacin (3mg/Kg/day) (n=16) 
Group D – Celecoxib (5mg/Kg/day) (n=17) 
Group E - Celecoxib (10mg/Kg/day) (n=16) 
Group F - Celecoxib 20mg/Kg/day) (n=16) 
Group B-F animals were treated with 10% sodium chloride (in the initial 
6 weeks) and MNNG in drinking water to induce adenocarcinoma in the 
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stomach. All animals received treatment for 40 weeks, and were 
sacrificed after death or at 48 weeks. Gastric neoplasm was evaluated by 
histology. The incidences of gastric cancer were 0%in group A, 75% in 
group B, 68.8% in group C, 70.6% in group D, 18.8% in group E and 
31.3 % in group F. Compared with MNNG controls, treatment with 
celecoxib 10mg/kg/day also showed  lower tumour multiplicity and lower 
mean tumour volume. The tumours had significantly higher COX-2 
expression than their adjacent normal tissues (p < 0.02). There was no 
significant difference in COX-2 levels among tumours in the different 
treatment groups. Lower tumour prostaglandin E2 level was found in the 
indomethacin treated group, suggesting that the chemo preventive effect 
of celecoxib may be mediated by a COX-2 independent pathway (14). 
 
Having proven that COX-2 expression is much higher in these tumours, 
and that treatment with selective COX-2 drugs does decrease the tumour 
load, it may sound logical to give COX-2 inhibitors to all patients 
diagnosed to have early pre-cursor lesions of gastric cancer or those who 
are at a higher risk of developing gastric cancer.  
VIGOR (Vioxx Gastrointestinal Outcomes Research Study) study, which 
was initially designed to assess whether rofecoxib is associated with a 
lower incidence of clinically important upper gastrointestinal events than 
naproxen in patients with rheumatoid arthritis, showed the relative risk of 
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developing a confirmed adjudicated thrombotic cardiovascular event 
(myocardial infarction, unstable angina, cardiac thrombus, resuscitated 
cardiac arrest, sudden or unexplained death, ischaemic stroke and 
transient ishcaemic attacks) with rofecoxib treatment in comparison to 
that with naproxen was 2.38 (p= 0.002) (15).  Rofecoxib was withdrawn 
from the market. In an APC cancer trial, the drug company Pfizer 
demonstrated an increased cardiovascular risk over placebo for celecoxib 
and thus the drug was withdrawn. The US FDA issued a Public Health 
Advisory, which stated that the long term use of NSAIDs and selective 
COX-2 inhibitors might increase the risk of severe cardiovascular events.  
 
With this background, the role of aspirin, a drug very commonly used 
especially in patients with history of cardiovascular events was chosen to 
study its chemo protective properties. 
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Aspirin and its mechanism of action – 
 
 
Aspirin exerts its effects predominantly through its antiprostaglandin 
activity. Cyclooxygenase (COX) is the key enzyme in the synthesis of 
prostaglandins from arachidonic acid, which is inhibited by aspirin. 
 
 
 
 
Two isoenzymes have been identified for cyclooxygenase – 
Cyclooxygenase 1 (COX 1) and Cyclooxygenase 2 (COX 2). Aspirin 
covalently modifies both COX 1 and COX 2 thus causing an irreversible 
inhibition of Cyclooxygenase activity. Duration of action is related to the 
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turnover rate of Cyclo-oxygenases in different target tissues. Aspirin 
acetylates serine 530 of COX 1 and prevents binding of arachidonic acid 
to the active site of the enzyme. It acetylates serine 516 of COX 2 leading 
to the formation of 15( R )- hydroxyl eicosatetraenoic acid which is 
converted to 15 – epilipoxin A4 and this potentiates the anti-
inflammatory action of Aspirin ( Goodman and Gillman’s 
Pharmacological Basis of Therapeutics – 10th ed.).  
 
Cyclooxygenase 1 (COX-1) is constitutively expressed and considered to 
be a housekeeping gene, while Cyclooxygenase 2 (COX-2) is not usually 
detectable in normal tissues, but can be readily induced in processes like 
inflammation, reproduction and carcinogenesis. The mechanisms by 
which COX-2 is thought to be involved in the carcinogenesis include (16)  
 
a) Resisting apoptosis 
 
b) Increasing cell proliferation 
 
c) Stimulating angiogenesis 
 
d) Modulating the invasive properties of cancer cells 
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COX-2 is inducible by oncogenes ras and scr, interleukin-1, hypoxia, 
benzo[a]pyrene, ultraviolet light, epidermal growth factor, transforming 
growth factor beta, and tumour necrosis factor alpha. Dexamethasone, 
antioxidants, and tumour-suppressor protein p53 suppress COX-2 
expression. COX-2 synthesizes prostaglandin E2 (PGE2) which 
stimulates bcl-2 and inhibits apoptosis, and induces interleukin-6 (IL-6) 
which enhances haptoglobin synthesis. PGE2 is associated with tumour 
metastases, IL-6 with cancer cell invasion, and haptoglobin with 
implantation and angiogenesis (17). 
 
A clear positive correlation between COX-2 expression and inhibition 
of apoptosis has been established, associated with increased PGE2 
levels resulting in modulation of pro- and anti-apoptotic factors (e.g., 
bcl-2, MAKs/ras, caspase-3, Par-4). In terms of angiogenesis and 
invasiveness, COX-2 activity was found to increase the expression of 
growth factors (e.g., VDEG, PDGF, bFGF) and matrix 
metalloproteinases (MMPs) (18). 
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Prostaglandins – Their role in cancer 
development  
 
 
Maxwell et al confirmed that the blood from the veins draining the tumor 
especially from the gastrointestinal tract is found to have high 
prostaglandin E2. There was no statistically significant difference in the 
prostaglandin biosynthetic capacity of epithelial cells derived from 
tumour tissue compared to epithelial cells derived from uninvolved tissue. 
However significant difference in biosynthetic capacity was observed 
between tissue fixed mononuclear cells derived form tumours compared 
to uninvolved tissue. There was no difference in prostaglandin E2 
synthesis observed between peripheral mononuclear cells derived from 
colon cancer patients or from normal individuals. The aggregates of these 
observations suggest that the host cells rather than the tumour cells may 
be the major source of prostaglandins that contribute to tumourogenesis 
(19).  
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Possible mechanism of malignant transformation and growth linked 
to prostaglandin (PG) synthesis – 
 
1) Mutagenesis – Melonaldehyde is a breakdown product of 
prostaglandin H2, which acts as a mutagenic as well as 
carcinogenic agent. Aspirin, by inhibiting Cyclooxygenase, reduces 
the synthesis of prostaglandins, so melonaldehyde production is 
reduced as it a byproduct of PG breakdown (19). 
 
2) Prostaglandin synthesis dependant carcinogen activation – PG 
synthase dependant xenobiotic metabolism has been demonstrated 
in several intact cellular systems. Aromatic amines, heterocyclic 
amines and dihydrodiol derivatives of polycyclic hydrocarbons are 
activated to mutagenic derivatives by PG synthase.  Aspirin, by 
inhibiting PG synthetase, decreases these mutagenic derivatives 
(19). 
 
3) Cell growth – Experimental animal studies have shown that 
mammary epithelial cell lines are stimulated by Thromboxane A2 
and inhibited by thromboxane A2 inhibitors. Thromboxane A2 is a 
breakdown product of prostaglandins, so aspirin, by blocking the 
 34
synthesis of prostaglandins, reduces the production of thromboxane 
A2 (19). 
 
4) Tumour promotion – PG are found to have a role in tumour 
promotion in the epidermis of mice by phobol esters. Phorbol 
esters are present in the epidermal cells. Administration of tumour 
promoting phorbol esters to mouse skin in cultured murin 
keratinocytes triggers the release of arachidonic acid, which will 
lead on to PG synthesis. Aspirin, by inhibiting the PG synthesis 
from arachidonic acid, reduces tumour production. (19). 
 
5) Immune response – Another mechanism by which cyclooxygenase 
inhibitors may decrease tumourogenesis is by modulation of 
immune response. Colony stimulating factors from macrophages 
activate monocytes to produce PG E2, which inhibits the 
blastogenesis of T-cells and cytotoxic activity of natural killer 
cells. This appears to be part of a generalized response of the 
immune system to the presence of foreign antigen (19). 
 
6) Anti-platelet action – Aspirin prevents platelet aggregation to 
tumour cells thereby preventing the platelet tumour cell aggregate 
to get attached to the capillary endothelium.  By this, the lodging of 
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tumour cells gets prevented. They also provide an immunological 
shield to the tumour cells. The efficacy of low dose aspirin as an 
antiplatelet suggests that inhibition of platelet function should be 
considered as a mechanism for inhibition for cancer mortality. 
Metastatic disease is frequently the cause of death from cancer and 
inhibition of metastasis certainly has a significantly beneficial 
effect on the mortality of colon cancers. (20). 
 
Thun et all studied that platelet  is the only cell type sensitive to inhibition  
by low to moderate dose of aspirin, but slow to cyclooxygenase activity. 
The importance of PG especially thromboxane A2 and its role in the 
regulation of platelet function is the basis for a reason for interrupting the 
metastatic cascade. Although there are some reports indicating the lack of 
an anti-metastatic effect on aspirin, it may be related to difference in 
dosage, route of administration, preparation of tumour cells on metastasis 
used (20). 
Recent studies have shown that Aspirin induces apoptosis (21, 22) thus 
exerting its anti-tumourigenic action. 
 
 
 
 
 
 36
Vitamin C, antioxidants and free radicals: 
 
 
 
Free radicals are chemicals with a single unpaired electron in their outer 
orbit. They are extremely unstable and readily react with organic or 
inorganic chemicals. They attack and degrade nucleic acids as well as a 
variety of membrane molecules. They also initiate autocatalytic reactions. 
Molecules that interact with these free radicals are in turn converted to 
free radicals thus propagating chain of damage. 
Free radicals can be generated in cells by  
a) Absorption of radiant energy (x-rays, UV rays) 
b) Reduction-oxidation reactions that occur during normal 
physiologic process. 
c) Enzymatic metabolism of exogenous chemicals 
 
Three reactions are particularly relevant to cell injury mediated by free 
radicals: 
 
1. Lipid peroxidation of membranes : Double bonds in membrane 
polyunsaturated lipids are vulnerable to attack by oxygen-derived 
free radicals 
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2. Lesions in DNA : Reactions with thymine in nuclear and 
mitochondrial DNA produce single strand breaks which has been 
implicated in both cell death and malignant transformation 
3. Cross-linking of proteins: These radicals promote sulfhydryl-
mediated protein cross-linking, resulting in enhanced rates of 
degradation or loss of enzymatic activity. They may also cause 
poly peptide fragmentation.  
 
Free radical formation is also a part of the normal physiology including 
microbial defence and respiration. Therefore the cells have developed 
mechanisms to minimize the injury produced by these generated free 
radicals. Free radicals are inherently unstable and generally decay 
spontaneously. Superoxide dismutase significantly increases the rate of 
decay of these free radicals. Another enzymes, such as glutathione 
peroxidise, also protect against injury. Exogenous and endogenous 
antioxidants (Vitamin E) may either block free radical formation or 
scavenge them once they are formed. 
(Basic Pathology. Kumar, Cotran, Robbins) 
 
Generation of reactive oxygen species is another important causative 
factor for production of gastric cancer. The gastro intestinal tract is 
particularly susceptible to reactive oxygen species attack which leads to 
 38
carcinogenesis. Antioxidants play an important role in preventing tumour 
induction.  
 
Skrzydlewska  and his associates studied the activity of  superoxide 
dismutase, catalase, glutathione peroxidise, reductase, the level of 
glutathione, vitamin C, malondialdehyde and cancer procoagulant in 
tumours and nomal mucosa from 18 patients with esophageal cancer, 18 
patients with gastric tumour and 62 patients with colorectal cancer. An 
increased activity of these enzymes was noted.  In gastric cancer patients, 
the activity of glutathione peroxidase and reductase was decreased. There 
seemed to be an imbalance in the antioxidant potential which led to 
increase in reactive oxygen species action. (13). 
 
Skrzydlewska also found a statistically significant increase in the level of 
lipid peroxidation products in patients with colorectal cancer. Also the 
levels of Vitamin C and E were also reduced thereby proving that 
colorectal carcinogenesis was associated with serious oxidative stress and 
that gradual advancement of oxidative-antioxidative disorders was 
followed by progression of colorectal cancer. (24). 
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From various animal studies, it has been clearly shown that an imbalance 
in the regulation of regeneration of free oxygen radicals leads to the 
formation of malignancy.  
 
Gastric juice contents were analyzed in one study to assess the levels of 
ascorbic acid, total bile acids, nitrite, nitrate and total nitroso compounds 
(NOCs) in 56 patients with non-operated stomachs undergoing endoscopy 
for dyspepsia. It was found that patients with chronic atrophic gastritis 
had lower gastric juice ascorbic acid concentrations, higher pH than 
normal subjects which were significant. Patients with reflux gastritis had 
higher total bile acid concentrations and lower gastric ascorbic acid 
concentrations than those with chronic gastritis and no intestinal 
metaplasia. There was however no significant differences in plasma 
vitamin C or gastric nitrite, nitrate or total NOC concentrations in relation 
to gastric histology. (25). 
 
The role of ascorbic acid (Vitamin C) in cancer production has been 
unclear. Though there are studies that show low levels of Vitamin C in 
patients with gastric cancer, there are others that show that vitamin C 
intake enhances gastric cancer production. However, because of its 
antioxidant properties, its role as a protective substance has also been 
considered in this study.  
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Materials and Methods 
 
 
 
This experiment was conducted on the Wistar breed of rats. The animals 
were obtained from the National Centre for Biological Sciences, 
Bangalore. Total number of rats required to conduct this experiment was 
60. This sample size was obtained using the data from the study 
conducted by P.J. Hu et al on rats where gastric cancer was induced using 
a carcinogen.   
 
Approval of the college research board and the animal ethics committee 
was obtained before the commencement of the study. The rats were 
divided in to 3 groups, each group having 20 rats. The rats were caged 
together in fours. The experiment was conducted in the Animal 
Laboratory under controlled environmental conditions.  The room 
temperature was maintained at 24 to 26 degrees. Humidity was 
maintained at 50 to 60 %.  The light cycle period was 14 hours of day and 
10 hours of night. The rats were given regular rat feeds along with supply 
of fresh water.  The feed was a standard rat feed and was available ad 
libitum.  Bedding changes were made twice weekly. Polypropylene cages 
were used to house the animals. A veterinary doctor was available to 
monitor the health of the rats.  
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Group A N = 20 
Group B N = 18 
Group C N = 20 
 
(2 rats had died within 12 weeks of initiating the experiment) 
 
 
 
The rats were initially quarantined. After dividing them in to their 
respective groups, they were fed with regular food pellets and water for 
one week duration for acclimatization after which the experiment was 
initiated. Carcinogen, aspirin and vitamin C were all given with drinking 
water.  
 
 
 
Drug delivery: 
 
 
 
The first group received Carcinogen only along with drinking water. The 
second group received carcinogen and aspirin, both mixed with drinking 
water. Dispensable aspirin tablets were used. The third group was given 
aspirin, vitamin C and the carcinogen. The carcinogen was initially 
dissolved in the appropriate solvent and then made into the required 
concentration and packaged in vials. Each vial contained 38 mg of the 
carcinogen for every 5 ml of solution.  The food and water were changed 
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everyday. The respective drugs were mixed in water and distributed 
equally for each rat and cage – 40 ml of the solution for each rat.  Any 
left over solution was discarded and fresh solution was prepared for the 
next day.  If the assigned drug-water solution was consumed completely 
before 24 hours, fresh drinking water was supplied without the drug(s). 
 
A period of 12 weeks was allotted for assessment of drug over dosage or 
drug toxicity. Rats dying within 12 weeks of initiating the experiment 
were not considered in the study and this was thought to be due to drug 
toxicity.  
 
The initial plan was to carry out the study for seven months. How ever as 
there were no tumours detected in the specimens of the rats that had died 
before the end the experiment or were sacrificed at the end of 7 months, 
the duration of the experiment was extended to one year with a higher 
concentration of the carcinogen, given along with drinking water and 
prepared by the same method.  
 
At the end of 7 months, 11 rats were initially sacrificed but as there was 
no evidence of malignancy, both in gross appearance and on histological 
examination, the experiment was continued for another 5 months, a total 
of one year. 
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Autopsy and Histopathological Examination: 
 
 
 
 
The rats were first subjected to anaesthesia. High dose of chloroform in a 
closed container was used. After inhalation of the anaesthetic gas at such 
high doses, death occurred within 3-4 minutes. After this the autopsy was 
performed. The abdominal viscera were examined for any evidence of 
tumours. One of the rats developed a liver mass. The stomach along with 
the esophagus (distal 2/3) was removed. Gross examination of the tissues 
was done for tumours. Half of the tissue that was removed was fixed in 
formalin for histopathology examination. The remaining tissue was stored 
for further immunohistochemisty studies.  
 
 
The specimen was first fixed in 10% formalin for 24 hours. 
Representative samples were taken by the pathologist and these were 
placed in cassettes. These cassettes were placed in an automated 
Histokine machine where there were subjected to different concentrations 
of alcohol (70%, 80%, 90%), Touludine or Acetone, 2 baths of paraffin 
and finally Xylene. During this process, the tissue gets embedded in 
paraffin and the paraffin impregnates in to the tissue. The paraffin blocks 
were cooled on ice. The paraffin blocks were cut to a thickness of 5 
microns using a microtome. The sections were placed in a hot water bath 
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and transferred on to a glass slide. Glycerine was used to transfer the 
sections on to the glass slide. These were then subjected to incubation at 
37 degrees for 45 minutes following which H&E staining was done. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 45
Results 
 
 
 Both gross and histological examination failed to reveal the presence of 
any malignancy. Pre-cancerous conditions such as dysplasia also were not 
found in any of the tissues. The carcinogen used failed to induce any 
malignant changes in the tissues.  
 
 
 
Group A 
– Gross 
Group A – 
Microscopic 
Group B 
– Gross 
Group B – 
Microscopic
Group C 
– Gross 
Group C - 
Microscopic
- - - - - - 
- - - - - - 
- - - - - - 
- - - - - - 
- - - - - - 
- - - - - - 
- - - - - - 
- - - - - - 
- - - - - - 
- - - - - - 
- - - - - - 
- - - - - - 
- - - - - - 
- - - - - - 
- - - - - - 
- - - - - - 
- - - - - - 
- - - - - - 
- -   - - 
- -   - - 
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Discussion 
 
 
 
 
There were two deaths during the initial 12 weeks. The exact cause of 
death could not be identified. Autopsy of these rats did not reveal any 
evidence of gross tumour but histopathological evaluation for any 
evidence of microscopic tumour was not possible as the rats had died 
overnight and had already begun to decompose. These rats were not 
included in the study. 
 
During the course of the experiment, there was a period of sudden death 
of these rats occurring over a very short period. The autopsy performed 
on these rats did not however reveal any features of malignancy, both on 
gross examination and on histological examination. As rats being used for 
other experiments also began to die, a common factor such as temperature 
regulation was thought to be the cause for these sudden deaths. After the 
temperatures were strictly regulated, these deaths stopped occurring. 
However there were other cases of deaths that occurred even after this. 
As the animals were caged in groups of four, there were occasional 
conflicts amongst the members of the same cage resulting in death of one 
of the animals as confirmed by bite marks. This was not a common 
phenomenon and hence they remained in groups.  
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Another interesting phenomenon that occurred was loss of hair and 
ulceration of the foot pad with loss of toes. This was not restricted to any 
one group. A veterinary doctor was consulted for this condition and this 
was thought to be due to a skin infection. Despite necessary medications, 
this condition did not seem to improve with medications. Also, as the 
duration of the experiment was prolonged, the age factor was also 
considered to be responsible for the hair loss.   
 
 
This study eventually did not produce any positive results. The 
carcinogen used failed to induce any features of malignancy in the tissues 
including microscopic changes such as dysplasia. Hence the effect of 
aspirin and vitamin C could not be evaluated. The following have been 
considered to be responsible for the above results. 
 
1. The carcinogen used in the experiment was not a very potent 
carcinogen in terms of its carcinogenic effect on gastric 
tissues. The initially planned carcinogen was N-Methyl-N ‘-
Nitro-N-Nitrosoguanidine (MNNG) which is a very potent 
carcinogen and used very extensively in animal experiments 
to produce a gastric cancer in animal models, especially rats. 
As this compound was not available, an alternative 
compound was used in the study. The failure of this 
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compound to induce cancer may have also been due to the 
fact that during shipping of this product, its potency may 
have been lost. Also the potency may have been lost during 
storage of this compound. Another reason may have been 
due to inadequate dosage used. Perhaps a higher dose of the 
carcinogen should have been used. This was thought of after 
7 months, and a much higher dose was used for 5 months. 
Despite this modification in the dosage no features of 
malignancy were found. 
2. Resistant strains: Resistant laboratory animals (rat strains) 
have been bred which have shown resistance to development 
of cancer induced by carcinogen.   Experiments conducted 
by  Hiroko and colleagues in rats showed that resistance to 
induction of gastric adenocarcinoma by carcinogen (MNNG) 
was a dominant characteristic in certain strains of laboratory 
bred rats (5). 
 
Presence of resistant strains leads us in a new direction of research – the 
possible mechanisms of resistance. What are the underlying molecular 
mechanisms that promote resistance to cancer production and can this 
information be used to produce resistance to cancer in humans. 
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(Pic 1 – At the end of the experiment) 
 
 
 
(Pic 2 – Loss of hair over the head) 
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(Pic 3 - Foot ulceration) 
 
 
 
(Pic 4 - Hair loss over the body) 
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Medium Power view of gastro-esophageal junction showing 
keratinized esophageal epithelium 
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High power view of esophageal epithelium showing mild dysplasia 
and no evidence of malignancy 
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Conclusions 
 
 
 
In conclusion, the negative results of this study can be attributed to two 
factors – 
 
a) The carcinogen used in the experiment was not a very potent 
carcinogen in terms of its carcinogenic effect on gastric tissues. 
b) It is possible that resistant laboratory animals (rat strains) have been 
bred which have shown resistance to the development of cancer 
induced by carcinogen. 
 
Mankind continues to struggle for survival in his war against cancer. 
Though extensive research has been done in the field of cancer science, 
both in its etiopathogenesis and also in its treatment, search for better and 
appropriate modalities of treatment continues. Some of them such as 
gastric cancer are silent killers and detected quite late.   Preventive 
measures may be instituted in those that are at high risk or in those early 
pre-cancerous lesions have been detected. Finding preventive measures 
will go a long way in saving lives than finding a cure. 
 
Prevention is better than cure! 
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Future directions 
 
Further studies could be conducted in the future to produce an animal 
model for gastric cancer.  Though such models have been successfully 
created using MNNG compound,  experiments using other nitrosamine 
compounds could be conducted to produce these animal models and this 
model be used to study the characteristics of gastric cancer at a molecular 
level including genetic studies, such as its induction, progression and 
metastasis. Experiments utilizing surgical procedures that produce reflux 
of duodenal contents in to the stomach could also be conducted to study 
the effect of reflux on gastric cancer induction. Such information could be 
used further to find a cure for the disease or a preventive measure.   
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